Knopp Biosciences Partners with MMS Holdings Inc. to Manage Pharmacovigilance Services
Canton, MI (August 1, 2013) – MMS Holdings Inc. today announced that it has been selected to partner with Knopp Biosciences to provide best-in-class pharmacovigilance services in support of their compound, dexpramipexole. The MMS Holdings team offers an efficient, adaptable … Continued